Who are Acne Free, Proactiv's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Benzoyl peroxide and sulfur.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/acne-free-proactiv.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Acne Free, Proactiv — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acne Free, Proactiv (Acne Free, Proactiv) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical acne treatment combination. Area: Dermatology.

marketed Topical acne treatment combination Cutibacterium acnes; follicular keratinocytes Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Acne Free, Proactiv (Acne Free, Proactiv) — MedDerm Associates. Proactiv and Acne Free are topical acne treatment systems that work by reducing bacteria, unclogging pores, and reducing inflammation through a combination of benzoyl peroxide and salicylic acid.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Acne Free, Proactiv TARGET	Acne Free, Proactiv	MedDerm Associates	marketed	Topical acne treatment combination	Cutibacterium acnes; follicular keratinocytes
Benzoyl peroxide and sulfur	Benzoyl peroxide and sulfur	Zurita Laboratorio Farmaceutico Ltda.	marketed	Topical acne treatment combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical acne treatment combination class)

MedDerm Associates · 1 drug in this class
Zurita Laboratorio Farmaceutico Ltda. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Acne Free, Proactiv — Competitive Intelligence Brief. https://druglandscape.com/ci/acne-free-proactiv. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing